Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-18

FDA Approved: GLYBURIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic diabetes drug glyburide from Heritage Pharmaceuticals (Avet) under ANDA 090937.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)